The impaired clinical recovery in both acute and repair phases of colitis in mice treated with MLT could be linked to the increase in circulating leukocyte and TNF production in the colon, despite reduced IL-17 cytokine, which is fundamental for gut immunity in the control of bacteria burden [9]. Here, IL17A is linked to colitis.